Gossamer Bio Revenue vs. Operating Margin
| GOSS Stock | USD 2.48 0.07 2.90% |
Total Revenue | First Reported 2017-12-31 | Previous Quarter 11.5 M | Current Value 13.3 M | Quarterly Volatility 17.1 M |
For Gossamer Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Gossamer Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Gossamer Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Gossamer Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Gossamer Bio over time as well as its relative position and ranking within its peers.
Check out Risk vs Return Analysis. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gossamer Bio. If investors know Gossamer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gossamer Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share | Quarterly Revenue Growth 0.402 | Return On Assets | Return On Equity |
The market value of Gossamer Bio is measured differently than its book value, which is the value of Gossamer that is recorded on the company's balance sheet. Investors also form their own opinion of Gossamer Bio's value that differs from its market value or its book value, called intrinsic value, which is Gossamer Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gossamer Bio's market value can be influenced by many factors that don't directly affect Gossamer Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gossamer Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Gossamer Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gossamer Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Gossamer Bio Operating Margin vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Gossamer Bio's current stock value. Our valuation model uses many indicators to compare Gossamer Bio value to that of its competitors to determine the firm's financial worth. Gossamer Bio is rated # 3 in revenue category among its peers. It is rated # 4 in operating margin category among its peers . At this time, Gossamer Bio's Total Revenue is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Gossamer Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Gossamer Revenue vs. Competition
Gossamer Bio is rated # 3 in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 543.58 Million. Gossamer Bio totals roughly 114.7 Million in revenue claiming about 21% of equities under Health Care industry.
Gossamer Operating Margin vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Gossamer Bio |
| = | 114.7 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Gossamer Bio |
| = | (3.13) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Gossamer Operating Margin Comparison
Gossamer Bio is currently under evaluation in operating margin category among its peers.
Gossamer Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Gossamer Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Gossamer Bio will eventually generate negative long term returns. The profitability progress is the general direction of Gossamer Bio's change in net profit over the period of time. It can combine multiple indicators of Gossamer Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 1.4 M | 1.4 M | |
| Net Interest Income | -8.8 M | -9.2 M | |
| Interest Income | 2 M | 1.6 M | |
| Operating Income | -53.9 M | -56.6 M | |
| Net Loss | -50.9 M | -53.4 M | |
| Income Before Tax | -50.1 M | -52.6 M | |
| Total Other Income Expense Net | 3.9 M | 4 M | |
| Net Loss | -206.4 M | -216.8 M | |
| Net Loss | -50.9 M | -53.4 M | |
| Income Tax Expense | 1 M | 975.6 K | |
| Non Operating Income Net Other | 2.8 M | 2.8 M | |
| Change To Netincome | 48.9 M | 33.7 M | |
| Net Loss | (0.29) | (0.30) | |
| Income Quality | 0.06 | 0.05 | |
| Net Income Per E B T | 0.91 | 0.82 |
Gossamer Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Gossamer Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Gossamer Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Gossamer Bio's important profitability drivers and their relationship over time.
Gossamer Bio Earnings Estimation Breakdown
The calculation of Gossamer Bio's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Gossamer Bio is estimated to be -0.21 with the future projection ranging from a low of -0.24 to a high of -0.19. Please be aware that this consensus of annual earnings estimates for Gossamer Bio is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.24 Lowest | Expected EPS | -0.19 Highest |
Gossamer Bio Earnings Projection Consensus
Suppose the current estimates of Gossamer Bio's value are higher than the current market price of the Gossamer Bio stock. In this case, investors may conclude that Gossamer Bio is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Gossamer Bio's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 8 | 87.98% | 0.0 | -0.21 | -0.69 |
Gossamer Bio Earnings per Share Projection vs Actual
Actual Earning per Share of Gossamer Bio refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Gossamer Bio predict the company's earnings will be in the future. The higher the earnings per share of Gossamer Bio, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Gossamer Bio Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Gossamer Bio, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Gossamer Bio should always be considered in relation to other companies to make a more educated investment decision.Gossamer Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Gossamer Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-11-05 | 2025-09-30 | -0.19 | -0.21 | -0.02 | 10 | ||
2025-08-05 | 2025-06-30 | -0.1805 | -0.17 | 0.0105 | 5 | ||
2025-05-05 | 2025-03-31 | -0.19 | -0.16 | 0.03 | 15 | ||
2025-03-03 | 2024-12-31 | -0.168 | -0.15 | 0.018 | 10 | ||
2024-11-07 | 2024-09-30 | -0.15 | -0.14 | 0.01 | 6 | ||
2024-08-06 | 2024-06-30 | 0.23 | 0.22 | -0.01 | 4 | ||
2024-05-07 | 2024-03-31 | -0.19 | -0.19 | 0.0 | 0 | ||
2024-03-05 | 2023-12-31 | -0.21 | -0.21 | 0.0 | 0 | ||
2023-11-09 | 2023-09-30 | -0.26 | -0.21 | 0.05 | 19 | ||
2023-08-08 | 2023-06-30 | -0.49 | -0.45 | 0.04 | 8 | ||
2023-05-09 | 2023-03-31 | -0.53 | -0.52 | 0.01 | 1 | ||
2023-03-17 | 2022-12-31 | -0.62 | -0.59 | 0.03 | 4 | ||
2022-11-03 | 2022-09-30 | -0.64 | -0.65 | -0.01 | 1 | ||
2022-08-09 | 2022-06-30 | -0.7 | -0.74 | -0.04 | 5 | ||
2022-05-10 | 2022-03-31 | -0.77 | -0.76 | 0.01 | 1 | ||
2022-03-03 | 2021-12-31 | -0.74 | -0.74 | 0.0 | 0 | ||
2021-11-08 | 2021-09-30 | -0.78 | -0.8 | -0.02 | 2 | ||
2021-08-09 | 2021-06-30 | -0.76 | -0.8 | -0.04 | 5 | ||
2021-05-06 | 2021-03-31 | -0.75 | -0.78 | -0.03 | 4 | ||
2021-02-25 | 2020-12-31 | -0.79 | -0.88 | -0.09 | 11 | ||
2020-11-10 | 2020-09-30 | -0.85 | -0.8 | 0.05 | 5 | ||
2020-08-11 | 2020-06-30 | -0.86 | -1.0 | -0.14 | 16 | ||
2020-05-12 | 2020-03-31 | -0.8 | -0.87 | -0.07 | 8 | ||
2020-03-24 | 2019-12-31 | -0.86 | -0.89 | -0.03 | 3 | ||
2019-11-12 | 2019-09-30 | -0.69 | -0.8 | -0.11 | 15 | ||
2019-08-08 | 2019-06-30 | -0.56 | -0.74 | -0.18 | 32 | ||
2019-05-14 | 2019-03-31 | -0.65 | -0.9 | -0.25 | 38 | ||
2019-03-22 | 2018-12-31 | -1 | -18.23 | -17.23 | 1723 | ||
2018-10-11 | 2018-09-30 | 0 | -0.93 | -0.93 | 0 |
Use Gossamer Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Gossamer Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gossamer Bio will appreciate offsetting losses from the drop in the long position's value.Gossamer Bio Pair Trading
Gossamer Bio Pair Trading Analysis
The ability to find closely correlated positions to Gossamer Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Gossamer Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Gossamer Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Gossamer Bio to buy it.
The correlation of Gossamer Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Gossamer Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Gossamer Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Gossamer Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Gossamer Bio position
In addition to having Gossamer Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Global Macro ETFs Thematic Idea Now
Global Macro ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.